Tolterodine effectively attenuates catheter related bladder discomfort in kidney transplantation patients*★Symbol

  • Li, Jin-feng
  • Feng, Gui-wen
  • Wang, Yue
  • Pang, Xin-lu
  • Shang, Wen-jun
  • Liu, Lei
Journal of Clinical Rehabilitative Tissue Engineering Research 16(18):p 3241-3244, April 29, 2012.

Abstract

BACKGROUND:

Renal transplantation requires long term use of indwelling catheter, which could easily cause bladder irritation.

OBJECTIVE:

To assess the catheter related bladder discomfort using Overactive Bladder Symptom Score in kidney transplantation patients; to evaluate the efficiency of tolterodine in preventing catheter related bladder discomfort in kidney transplantation patients.

METHODS:

A total of 102 living-related kidney transplant recipients were involved in this study. Indwelling catheters were used after transplant; and patients were treated with 4 mg/d tolterodine or the same dose of placebo, respectively. The recipient bladder discomfort was assessed using Overactive Bladder Symptom Score at different time points.

RESULTS AND CONCLUSION:

The incidence and severity of urgency and urgency incontinence increased in kidney transplant patients with increasing catheter indwelling time. With the application of tolterodine, the incidence and severity of urgency and urgency incontinence decreased significantly. These findings indicate that regulated application of tolterodine may effectively prevent catheter related bladder discomfort in kidney transplantation patients.

Li JF, Feng GW, Wang Y, Pang XL, Shang WJ, Liu L. Tolterodine effectively attenuates catheter related bladder discomfort in kidney transplantation patients. Zhongguo Zuzhi Gongcheng Yanjiu. 2012;16(18): 3241–3244. [http://www.crter.cnhttp://en.zglckf.com]

Copyright © 2012 Publishing House of Neural Regeneration Research